Acute and subchronic exposure to air particulate matter induces expression of angiotensin and bradykinin-related genes in the lungs and heart: Angiotensin-II type-I receptor as a molecular target of particulate matter exposure

Particle and Fibre Toxicology

Volumn 12, Issue 1, 2015, Pages

  Aztatzi Aguilar, Octavio Gamaliel ^a   Uribe Ramírez, Marisela ^a   Arias Montaño, José Antonio ^a   Barbier, Olivier ^a   De Vizcaya Ruiz, Andrea ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Kallikrein kinin system; Particulate matter; Renin angiotensin aldosterone system

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN I; BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; COLLAGEN TYPE 3; DIPEPTIDYL CARBOXYPEPTIDASE; GLUTAMATE CYSTEINE LIGASE; HEME OXYGENASE 1; INTERLEUKIN 6; MESSENGER RNA; TISSUE KALLIKREIN; ACTIN; ANTIOXIDANT; COL3A1 PROTEIN, RAT; CYTOKINE; PARTICULATE MATTER;

ACE GENE; ACTA1 GENE; ACUTE EXPOSURE; AIRBORNE PARTICLE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; AT1 GENE; AT2R GENE; B1R GENE; B2R GENE; CELLULAR DISTRIBUTION; COL3A1 GENE; CONTROLLED STUDY; CORONARY ARTERY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; GENE; GENE EXPRESSION; HEART DISEASE; KALLIKREIN KININ SYSTEM; KLK 1 GENE; LONG TERM EXPOSURE; LUNG DISEASE; MALE; MEMBRANE BINDING; NONHUMAN; NUCLEAR REPROGRAMMING; PARTICULATE MATTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR BINDING ASSAY; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE INJURY; WESTERN BLOTTING; ADVERSE EFFECTS; ANIMAL; CARDIAC MUSCLE; COMPARATIVE STUDY; DRUG EFFECTS; EXPOSURE; GENE EXPRESSION REGULATION; GENETICS; LUNG; METABOLISM; PARTICLE SIZE; PATHOLOGY; SPRAGUE DAWLEY RAT; TIME FACTOR; TOXICITY;

RATTUS;

ACTINS; ANIMALS; ANTIOXIDANTS; COLLAGEN TYPE III; CYTOKINES; GENE EXPRESSION REGULATION; INHALATION EXPOSURE; KALLIKREIN-KININ SYSTEM; LUNG; MYOCARDIUM; PARTICLE SIZE; PARTICULATE MATTER; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; TIME FACTORS;

EID: 84933052773     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/s12989-015-0094-4     Document Type: Article

References (95)

1. Pope III CA, Dockery DW. Health effects of fine particulate air pollution: lines that connect. J Air Waste Manage Assoc. 2006;56:709-42.
2. Simkhovich BZ, Kleinman MT, Kloner RA. Air pollution and cardiovascular injury: epidemiology, toxicology, and mechanisms. J Am Coll Cardiol. 2008;52:719-26.
3. Pope CA, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, et al. Cardiovascular mortality and long-term exposure to particulate air pollution epidemiological evidence of general pathophysiological pathways of disease. Circulation. 2004;109:71-7.
4. Donaldson K, Stone V, Seaton A, MacNee W. Ambient particle inhalation and the cardiovascular system: potential mechanisms. Environ Health Perspect. 2001;109:523.
5. Mutlu GM, Green D, Bellmeyer A, Baker CM, Burgess Z, Rajamannan N, et al. Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway. J Clin Invest. 2007;117:2952-61.
6. Rhoden CR, Wellenius GA, Ghelfi E, Lawrence J, González-Flecha B. PM-induced cardiac oxidative stress and dysfunction are mediated by autonomic stimulation. Biochim Biophys Acta Gen Subj. 2005;1725:305-13.
7. Sharma JN. Role of tissue kallikrein-kininogen-kinin pathways in the cardiovascular system. Arch Med Res. 2006;37:299-306.
8. Kuhr F, Lowry J, Zhang Y, Brovkovych V, Skidgel R. Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors. Neuropeptides. 2010;44:145-54.
9. Thomas WG, Mendelsohn FA. Angiotensin receptors: form and function and distribution. Int J Biochem Cell Biol. 2003;35:774-9.
10. Lavoie JL, Sigmund CD. Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology. 2003;144:2179-83.
11. Iwai M, Horiuchi M. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens Res. 2009;32:533-6.
12. Tsutsumi Y, Matsubara H, Masaki H, Kurihara H, Murasawa S, Takai S, et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest. 1999;104:925.
13. Bergaya S, Hilgers RH, Meneton P, Dong Y, Bloch-Faure M, Inagami T, et al. Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors. Circ Res. 2004;94:1623-9.
14. Bhoola K, Figueroa C, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev. 1992;44:1-80.
15. Yousef GM, Diamandis EP. The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease 1. Endocr Rev. 2001;22:184-204.
16. Rueckschloss U, Quinn MT, Holtz J, Morawietz H. Dose-dependent regulation of NAD (P) H oxidase expression by angiotensin II in human endothelial cells protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2002;22:1845-51.
17. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916.
18. Dias JP, Talbot S, Sénécal J, Carayon P, Couture R. Kinin B1 receptor enhances the oxidative stress in a rat model of insulin resistance: outcome in hypertension, allodynia and metabolic complications. PLoS One. 2010;5, e12622.
19. Ni A, Yin H, Agata J, Yang Z, Chao L, Chao J. Overexpression of kinin B1 receptors induces hypertensive response to des-Arg9-bradykinin and susceptibility to inflammation. J Biol Chem. 2003;278:219-25.
20. Morand-Contant M, Anand-Srivastava MB, Couture R. Kinin B1 receptor upregulation by angiotensin II and endothelin-1 in rat vascular smooth muscle cells: receptors and mechanisms. Am J Physiol Heart Circ Physiol. 2010;299:H1625-32.
21. Kintsurashvili E, Duka I, Gavras I, Johns C, Farmakiotis D, Gavras H. Effects of ANG II on bradykinin receptor gene expression in cardiomyocytes and vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2001;281:H1778-83.
22. Harrison-Bernard LM, El-Dahr SS, O'Leary DF, Navar LG. Regulation of angiotensin II type 1 receptor mRNA and protein in angiotensin II-induced hypertension. Hypertension. 1999;33:340-6.
23. Gurantz D, Cowling RT, Villarreal FJ, Greenberg BH. Tumor necrosis factor-aα upregulates angiotensin II type 1 receptors on cardiac fibroblasts. Circ Res. 1999;85:272-9.
24. Wassmann S, Stumpf M, Strehlow K, Schmid A, Schieffer B, Böhm M, et al. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res. 2004;94:534-41.
25. Sasamura H, Nakazato Y, Hayashida T, Kitamura Y, Hayashi M, Saruta T. Regulation of vascular type 1 angiotensin receptors by cytokines. Hypertension. 1997;30:35-41.
26. Kranzhöfer R, Schmidt J, Pfeiffer CA, Hagl S, Libby P, Kübler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999;19:1623-9.
27. Tiffany CW, Burch RM. Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages. FEBS Lett. 1989;247:189-92.
28. Hayashi R, Yamashita N, Matsui S, Fujita T, Araya J, Sassa K, et al. Bradykinin stimulates IL-6 and IL-8 production by human lung fibroblasts through ERK-and p38 MAPK-dependent mechanisms. Eur Respir J. 2000;16:452-8.
29. Yayama K, Okamoto H. Angiotensin II-induced vasodilation via type 2 receptor: Role of bradykinin and nitric oxide. Int Immunopharmacol. 2008;8:312-8.
30. Brasier AR, Recinos A, Eledrisi MS. Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol. 2002;22:1257-66.
31. Kaplan AP, Joseph K, Silverberg M. Pathways for bradykinin formation and inflammatory disease. J allergy clin immunol. 2002;109:195-209.
32. Dielis AW, Smid M, Spronk HM, Hamulyak K, Kroon AA, ten Cate H, et al. The Prothrombotic Paradox of Hypertension Role of the Renin-Angiotensin and Kallikrein-Kinin Systems. Hypertension. 2005;46:1236-42.
33. Remková A, Remko M. The role of renin-angiotensin system in prothrombotic state in essential hypertension. Physiol Res. 2010;59.
34. Campbell D. Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides. Braz J Med Biol Res. 2000;33:665-77.
35. Su JB. Different cross-talk sites between the renin-angiotensin and the kallikrein-kinin systems. J Renin-Angiotensin-Aldosterone Syst. 2013;1470320312474854.
36. Schmaier AH. The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction. Am J Physiol Regul, Integr Comp Physiol. 2003;285:R1-R13.
37. Gillis C. Metabolism of vasoactive hormones by lung. Anesthesiology. 1973;39:626-32.
38. Zhang L, Wang H, Xiao Y, Cai Y, Ren J. Early lung injury contributes to lung fibrosis via AT1 receptor in rats. Acta Pharmacol Sin. 2007;28:227-37.
39. Myou S, Fujimura M, Kamio Y, Ishiura Y, Kurashima K, Tachibana H, et al. Effect of losartan, a type 1 angiotensin II receptor antagonist, on bronchial hyperresponsiveness to methacholine in patients with bronchial asthma. Am J Respir Crit Care Med. 2000;162:40-4.
40. Ulrich MM, Alink GM, Kumarathasan P, Vincent R, Boere AJF, Cassee FR. Health effects and time course of particulate matter on the cardiopulmonary system in rats with lung inflammation. J Toxicol Environ Health A. 2002;65:1571-95.
41. Gunnison A, Chen LC. Effects of subchronic exposures to concentrated ambient particles in mice: VI. gene expression in heart and lung tissue. Inhal toxicol. 2005;17:225-33.
42. Li Z, Carter JD, Dailey LA, Huang Y-CT. Pollutant particles produce vasoconstriction and enhance MAPK signaling via angiotensin type I receptor. Environ Health Perspect. 2005;113:1009.
43. Wold LE, Ying Z, Hutchinson KR, Velten M, Gorr MW, Velten C, et al. Cardiovascular remodeling in response to long-term exposure to fine particulate matter air pollution. Circ Heart Fail. 2012;5:452-61.
44. Ying Z, Yue P, Xu X, Zhong M, Sun Q, Mikolaj M, et al. Air pollution and cardiac remodeling: a role for RhoA/Rho-kinase. Am JPhysiol Heart Circ Physiol. 2009;296:H1540.
45. Rosati AM, Traversa U. Mechanisms of inhibitory effects of zinc and cadmium ions on agonist binding to adenosine A1 receptors in rat brain. Biochem Pharmacol. 1999;58:623-32.
46. 3 receptor is modulated by divalent cations. Eur J Pharmacol. 2000;394:189-97.
47. Marinissen MJ, Gutkind JS. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci. 2001;22:368-76.
48. Boivin B, Vaniotis G, Allen BG, Hebert TE. G protein-coupled receptors in and on the cell nucleus: a new signaling paradigm? J Recep Signal Transduction. 2008;28:15-28.
49. Lu D, Yang H, Shaw G, Raizada MK. Angiotensin II-Induced Nuclear Targeting of the Angiotensin Type 1 (AT1) Receptor in Brain Neurons 1. Endocrinology. 1998;139:365-75.
50. Tadevosyan A, Maguy A, Villeneuve LR, Babin J, Bonnefoy A, Allen BG, et al. Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression. J Biol Chem. 2010;285:22338-49.
51. Figueroa CD, Marchant A, Novoa U, Förstermann U, Jarnagin K, Schölkens B, et al. Differential distribution of bradykinin B2 receptors in the rat and human cardiovascular system. Hypertension. 2001;37:110-20.
52. McEachern AE, Shelton ER, Bhakta S, Obernolte R, Bach C, Zuppan P, et al. Expression cloning of a rat B2 bradykinin receptor. Proc Natl Acad Sci. 1991;88:7724-8.
53. Madeddu P, Emanueli C, Varoni MV, Demontis MP, Anania V, Gorioso N, et al. Regulation of bradykinin B2-receptor expression by oestrogen. Br J Pharmacol. 1997;121:1763-9.
54. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev. 2000;52:11-34.
55. Paradis P, Dali-Youcef N, Paradis FW, Thibault G, Nemer M. Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci. 2000;97:931-6.
56. Kim S, Ohta K, Hamaguchi A, Yukimura T, Miura K, Iwao H. Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension. 1995;25:1252-9.
57. Tsybouleva N, Zhang L, Chen S, Patel R, Lutucuta S, Nemoto S, et al. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Circulation. 2004;109:1284-91.
58. Sano M, Fukuda K, Kodama H, Pan J, Saito M, Matsuzaki J, et al. Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem. 2000;275:29717-23.
59. Schmid O, Möller W, Semmler-Behnke MA, Ferron G, Karg E, Lipka J, et al. Dosimetry and toxicology of inhaled ultrafine particles. Biomarkers. 2009;14:67-73.
60. Gould NS, Day BJ. Targeting maladaptive glutathione responses in lung disease. Biochem Pharmacol. 2011;81:187-93.
61. Cross CE, van der Vliet A, O'Neill CA, Louie S, Halliwell B. Oxidants, antioxidants, and respiratory tract lining fluids. Environ Health Perspect. 1994;102:185.
62. Otterbein LE, Choi AM. Heme oxygenase: colors of defense against cellular stress. Am J PhysioLung Cell Mol Physiol. 2000;279:L1029-37.
63. Abraham NG, Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radic Biolo Med. 2005;39:1-25.
64. Ryter SW, Otterbein LE, Morse D, Choi AM. Heme oxygenase/carbon monoxide signaling path-ways: Regulation and functional significance. In Oxygen/Nitrogen Radicals: Cell Injury and Disease. Springer; 2002. p. 249-63.
65. Idriss NK, Blann AD, Lip GY. Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol. 2008;52:971-8.
66. Fredenburgh LE, Perrella MA, Mitsialis SA. The role of heme oxygenase-1 in pulmonary disease. Am J Respir Cell Mol Biol. 2007;36:158-65.
67. Ishizaka N, Griendling KK. Heme oxygenase-1 is regulated by angiotensin II in rat vascular smooth muscle cells. Hypertension. 1997;29:790-5.
68. Li N, Wang M, Oberley TD, Sempf JM, Nel AE. Comparison of the pro-oxidative and proinflammatory effects of organic diesel exhaust particle chemicals in bronchial epithelial cells and macrophages. JImmunol. 2002;169:4531-41.
69. Danielsen PH, Møller P, Jensen KA, Sharma AK, Wallin H, Bossi R, et al. Oxidative stress, DNA damage, and inflammation induced by ambient air and wood smoke particulate matter in human A549 and THP-1 cell lines. Chem Res Toxicol. 2011;24:168-84.
70. Li N, Sioutas C, Cho A, Schmitz D, Misra C, Sempf J, et al. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect. 2003;111:455.
71. Sugimoto R, Kumagai Y, Nakai Y, Ishii T. 9, 10-Phenanthraquinone in diesel exhaust particles downregulates Cu, Zn-SOD and HO-1 in human pulmonary epithelial cells: Intracellular iron scavenger 1, 10-phenanthroline affords protection against apoptosis. Free Radic Biol Med. 2005;38:388-95.
72. Suzuki M, Betsuyaku T, Ito Y, Nagai K, Nasuhara Y, Kaga K, et al. Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2008;39:673-82.
73. Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, Shibahara S, et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet. 2000;66:187-95.
74. Kaneda H, Ohno M, Taguchi J, Togo M, Hashimoto H, Ogasawara K, et al. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol. 2002;22:1680-5.
75. Li H-J, Yin H, Yao Y-Y, Shen B, Bader M, Chao L, et al. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3β activation. Cardiovasc Res. 2007;73:130-42.
76. Meneton P, Bloch-Faure M, Hagege AA, Ruetten H, Huang W, Bergaya S, et al. Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice. Proc Natl Acad Sci. 2001;98:2634-9.
77. Borgoño CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer. 2004;4:876-90.
78. Christiansen SC, Proud D, Sarnoff RB, Juergens U, Cochrane CG, Zuraw BL. Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. Am Rev Respir Dis. 1992;145:900-5.
79. Sexton D, Chen T, Martik D, Kuzmic P, Kuang G, Chen J, et al. Specific inhibition of tissue kallikrein 1 with a human monoclonal antibody reveals a potential role in airway diseases. Biochem J. 2009;422:383-92.
80. Takimoto M, Mitani H, Hori S, Kimura M, Bandoh T, Okada T. Expression, secretion, and inhibition of angiotensin-converting enzyme in cultured human bronchial epithelial cells. Eur J Pharmacol. 1999;370:169-77.
81. Kohlstedt K, Gershome C, Friedrich M, Muller-Esterl W, Alhenc-Gelas F, Busse R, et al. Angiotensin-converting enzyme (ACE) dimerization is the initial step in the ACE inhibitor-induced ACE signaling cascade in endothelial cells. Mol Pharmacol. 2006;69:1725-32.
82. Kohlstedt K, Shoghi F, Müller-Esterl W, Busse R, Fleming I. CK2 phosphorylates the angiotensin-converting enzyme and regulates its retention in the endothelial cell plasma membrane. Circ Res. 2002;91:749-56.
83. Kohlstedt K, Busse R, Fleming I. Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells. Hypertension. 2005;45:126-32.
84. Mori Y, Matsubara H, Murasawa S, Kijima K, Maruyama K, Tsukaguchi H, et al. Translational regulation of angiotensin II type 1A receptor role of upstream AUG triplets. Hypertension. 1996;28:810-7.
85. Guerra R, Vera-Aguilar E, Uribe-Ramirez M, Gookin G, Camacho J, Osornio-Vargas A, et al. Exposure to inhaled particulate matter activates early markers of oxidative stress, inflammation and unfolded protein response in rat striatum. Toxicol Lett. 2013;222:146-54.
86. Kodavanti UP, Schladweiler MC, Gilmour PS, Wallenborn JG, Mandavilli BS, Ledbetter AD, et al. The role of particulate matter-associated zinc in cardiac injury in rats. Environ Health Perspect. 2008;13-20.
87. Hughes LS, Cass GR, Gone J, Ames M, Olmez I. Physical and chemical characterization of atmospheric ultrafine particles in the Los Angeles area. Environ Sci Technol. 1998;32:1153-61.
88. Utsunomiya S, Jensen KA, Keeler GJ, Ewing RC. Direct identification of trace metals in fine and ultrafine particles in the Detroit urban atmosphere. Environ Sci Technol. 2004;38:2289-97.
89. Lin C-C, Chen S-J, Huang K-L, Hwang W-I, Chang-Chien G-P, Lin W-Y. Characteristics of metals in nano/ultrafine/fine/coarse particles collected beside a heavily trafficked road. Environ Sci Technol. 2005;39:8113-22.
90. Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest. 2008;118:3546-56.
91. Camoretti-Mercado B, Solway J. Transforming growth factor-β1 and disorders of the lung. Cell Biochem Biophys. 2005;43:131-48.
92. Rosenkranz S. TGF-β1 and angiotensin networking in cardiac remodeling. Cardiovasc Res. 2004;63:423-32.
93. Zou Y, Akazawa H, Qin Y, Sano M, Takano H, Minamino T, et al. Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol. 2004;6:499-506.
94. Malhotra R, Sadoshima J, Brosius FC, Izumo S. Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes in vitro. Circ Res. 1999;85:137-46.
95. De Vizcaya-Ruiz A, Gutiérrez-Castillo M, Uribe-Ramirez M, Cebrián M, Mugica-Alvarez V, Sepúlveda J, et al. Characterization and in vitro biological effects of concentrated particulate matter from Mexico City. Atmos Environ. 2006;40:583-92.